Charu Aggarwal, MD, MPH | Authors


Delivering Precise Immunotherapy With NGS in NSCLC

July 17, 2019

Charu Aggarwal, MD, MPH, the Leslye M. Heisler Assistant Professor for Lung Cancer Excellence at Perelman School of Medicine, University of Pennsylvania, and other researchers conducted a prospective study using next-generation sequencing as a biomarker to predict response and progression-free survival rates in patients with non–small cell lung cancer receiving pembrolizumab monotherapy. The data were presented during the 2019 ASCO Annual Meeting.

Recent Advances in Head and Neck Squamous Cell Cancer

November 10, 2017

Head and neck squamous cell cancer is relatively uncommon in the United States compared to other malignancies like non-small–cell lung cancer and breast cancer. There are about 500,000 cases worldwide every year.